Literature DB >> 26906328

Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database.

Eisar Al-Sukhni1, Kristopher Attwood2, Emmanuel Gabriel3, Steven J Nurkin3.   

Abstract

INTRODUCTION: The circumferential resection margin (CRM) is a key prognostic factor after rectal cancer resection. We sought to identify factors associated with CRM involvement (CRM+).
METHODS: A retrospective review was performed of the National Cancer Database, 2004-2011. Patients with rectal cancer who underwent radical resection and had a recorded CRM were included. Multivariable analysis of the association between clinicopathologic characteristics and CRM was performed. Tumor <1 mm from the cut margin defined CRM+. RESULTS AND DISCUSSION: Of 23,464 eligible patients, 13.3% were CRM+. Factors associated with CRM+ were diagnosis later in the study period, lack of insurance, advanced stage, higher grade, undergoing APR, and receiving radiation. Nearly half of CRM+ patients did not receive neoadjuvant therapy. CRM+ patients who did not receive neoadjuvant therapy were more likely to be female, older, with more comorbidities, smaller tumors, earlier clinical stage, advanced pathologic stage, and CEA-negative disease compared to those who received it.
CONCLUSIONS: Factors associated with CRM+ include features of advanced disease, undergoing APR, and lack of health insurance. Half of CRM+ patients did not receive neoadjuvant treatment. These represent cases where CRM status may be modifiable with appropriate pre-operative selection and multidisciplinary management.
Copyright © 2016 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Pathology; Rectal neoplasms; Surgical

Mesh:

Year:  2016        PMID: 26906328      PMCID: PMC5295134          DOI: 10.1016/j.ijsu.2016.01.098

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  34 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Factors influencing circumferential resection margin in rectal cancer.

Authors:  A Hiranyakas; G da Silva; S D Wexner; Y-H Ho; D Allende; M Berho
Journal:  Colorectal Dis       Date:  2013-03       Impact factor: 3.788

3.  Local recurrence following total mesorectal excision for rectal cancer.

Authors:  G Arbman; E Nilsson; O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

4.  Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection.

Authors:  Deborah Schrag; Katherine S Panageas; Elyn Riedel; Laura D Cramer; Jose G Guillem; Peter B Bach; Colin B Begg
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

5.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Int J Surg       Date:  2014-07-18       Impact factor: 6.071

6.  Factors predicting the quality of total mesorectal excision for rectal cancer.

Authors:  Daniel Leonard; Freddy Penninckx; Steffen Fieuws; Anne Jouret-Mourin; Christine Sempoux; Constant Jehaes; Elizabeth Van Eycken
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

7.  Mesorectal grades predict recurrences after curative resection for rectal cancer.

Authors:  Sushil Maslekar; Abhiram Sharma; Alistair Macdonald; James Gunn; John R T Monson; John E Hartley
Journal:  Dis Colon Rectum       Date:  2007-02       Impact factor: 4.585

8.  Cancer-specific outcomes among young adults without health insurance.

Authors:  Ayal A Aizer; Benjamin Falit; Mallika L Mendu; Ming-Hui Chen; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Neil E Martin; Quoc-Dien Trinh; Brian M Alexander; Paul L Nguyen
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

9.  Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer.

Authors:  Sung Jin Oh; Jin Yong Shin
Journal:  J Korean Surg Soc       Date:  2012-02-27

10.  MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

Authors:  S Burton; G Brown; I R Daniels; A R Norman; B Mason; D Cunningham
Journal:  Br J Cancer       Date:  2006-02-13       Impact factor: 7.640

View more
  4 in total

1.  Can Post-Treatment MRI Features Predict Pathological Circumferential Resection Margin (pCRM) Involvement in Low Rectal Tumors.

Authors:  A Patra; A D Baheti; S K Ankathi; A Desouza; R Engineer; V Ostwal; A Ramaswamy; A Saklani
Journal:  Indian J Surg Oncol       Date:  2020-09-22

2.  Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Dao-Ning Liu; Ang Lv; Zhi-Hua Tian; Xiu-Yun Tian; Xiao-Ya Guan; Bin Dong; Min Zhao; Chun-Yi Hao
Journal:  Oncotarget       Date:  2017-01-31

Review 3.  The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.

Authors:  Fatima Domenica Elisa De Palma; Gaetano Luglio; Francesca Paola Tropeano; Gianluca Pagano; Maria D'Armiento; Guido Kroemer; Maria Chiara Maiuri; Giovanni Domenico De Palma
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

Review 4.  Endorectal Ultrasonography and Pelvic Magnetic Resonance Imaging Show Similar Diagnostic Accuracy in Local Staging of Rectal Cancer: An Update Systematic Review and Meta-Analysis.

Authors:  Gaetano Luglio; Gianluca Pagano; Francesca Paola Tropeano; Eduardo Spina; Rosa Maione; Alessia Chini; Francesco Maione; Giuseppe Galloro; Mariano Cesare Giglio; Giovanni Domenico De Palma
Journal:  Diagnostics (Basel)       Date:  2021-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.